Dr. Gary Sweeney

Degrees
BSc Pharmacology (University of Glasgow, UK)
PhD Molecular pharmacology (University of Glasgow, UK)
Appointments
Editorial board member, Diabetes
Associate Editor, Frontiers in Cellular Endocrinology
Editorial board member, American Journal of Physiology: Endocrinology and Metabolism
Chair, Fonds de la recherche en Santé du Québec (FRSQ) on-site review committee
Scientific officer, CIHR operating grants (Metabolism) review panel
Member, Heart & Stroke Foundation of Canada grant review committee
Member, Canadian Diabetes Association grant review committee
Member, Canadian Diabetes Association personnel awards review committee

Consulting experience
S.I. Healthcare
Diamed

Biography
Dr. Sweeney obtained his BSc and PhD in pharmacology at University of Glasgow, UK. He then moved to the Hospital for Sick Children in Toronto as postdoctoral fellow. Afterwards Dr. Sweeney was appointed as faculty member in the Department of Biology at York University where he is now Associate Professor. Dr. Sweeney has also served as Chief Scientific Officer and Diabetes Group Leader at Institut Pasteur Korea, a world-leading translational research institute. His research is funded by Canadian Institutes of Health Research, Canadian Diabetes Association and Heart & Stroke Foundation of Canada Korean Ministry of Education Science & Technology and AstraZeneca. Studies have resulted in publications in leading journals including Diabetes, Nature Reviews Cardiology, Proc Natl Acad Sci USA, Journal of Clinical Endocrinology & Metabolism, Journal of Biological Chemistry, Endocrinology and Cell Metabolism. These studies focus mainly on diabetes and cardiovascular disease, in particular the mechanisms linking obesity with diabetes and heart failure. He is recipient of academic awards from Canadian Diabetes Association, the Province of Ontario, Canadian Institutes of Health Research and Heart & Stroke Foundation of Ontario.